{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Spring Valley",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69999",
      "recalling_firm": "Par Pharmaceutical Inc.",
      "address_1": "1 RAM Ridge Rd",
      "address_2": "N/A",
      "postal_code": "10977-6714",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0332-2015",
      "product_description": "HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977",
      "product_quantity": "38,788 bottles",
      "reason_for_recall": "Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small  aluminum particles.",
      "recall_initiation_date": "20141124",
      "center_classification_date": "20150106",
      "termination_date": "20170501",
      "report_date": "20150114",
      "code_info": "Lot 26708501, Exp. 01/17",
      "more_code_info": ""
    }
  ]
}